Menu

More Details on How Pesticides Harm Bees

Scientists report that thiamethoxam exposure impairs bumblebees’ reproduction and honey bees’ ability to fly.

May 2, 2017
Diana Kwon

Bombus terrestris foraging on oil seed rape.DARA STANLEYSeveral bumblebee species are declining in both the United States and Europe, and earlier this year, the rusty patched bumblebee (Bombus affinis) was declared endangered by the US Fish & Wildlife Service. Studies suggest that a number of factors, including climate change and pesticides, are to blame.

See “First Bumblebee Species Declared Endangered in U.S.”

In a new study, published today (May 3) in Proceedings of the Royal Society B, scientists report that thiamethoxam, a neonicotinoid insecticide previously connected to population declines among honey bees and bumblebees, impairs the ability of queens bees to breed.

Researchers at the Royal Holloway University of London and the University of Guelph in Canada studied 506 queens across four bumblebee species (Bombus terrestrisB. lucorumB. pratorum, and B. pascuorum). “Almost nothing’s been done on queen bees and we wanted to understand what the impacts of neonics might be on queen behaviour and queen reproduction,” study coauthor Nigel Raine told the Globe and Mail.

See “Neonicotinoids May Harm Wild Bees

Their analysis revealed that thiamethoxam exposure impaired ovary development, and, in two of the species, resulted in less food intake. "We consistently found that neonicotinoid exposure, at levels mimicking exposure that queens could experience in agricultural landscapes, resulted in reduced ovary development in queens of all four species we tested," coauthor Gemma Baron said in a statement.

In another study, published last week (April 26) in Scientific Reports, scientists found that thiamethoxam exposure also altered honey bees’ ability to fly. “Honey bee survival depends on its ability to fly, because that’s the only way they can collect food,” coauthor Simone Tosi of the University of California, San Diego said in a statement. “Their flight ability is also crucial to guarantee crop and wild plant pollination.”

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.